Biomarkers of favorable vs. unfavorable responses in locally advanced rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy

HIGHLIGHTS

  • who: Hsin-Hua Lee and collaborators from the Department of Radiation Oncology, Medical University Hospital, Taiwan have published the research work: Biomarkers of Favorable vs. Unfavorable Responses in Locally Advanced Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy, in the Journal: Cells 2022, 11, 1611. of /2022/
  • what: The aim of this review is to inspect and analyze accessible data to fully realize the promise of precision oncology for rectal cancer patients. Whole-exome sequencing and gene_expression microarray analysis were conducted to investigate the genomic properties associated with CCRT response, with a study in 275 patients . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?